Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Hong Kong (TEA with LEM, TACE)

Completed
  • Hepatocellular Carcinoma
  • TEA with LEM
  • TACE
  • Hong Kong, Hong Kong
  • +2 more
Jan 21, 2015

Tumor, Hepatocellular Carcinoma Trial in Hong Kong (Pegylated Recombinant Human Arginase I)

Completed
  • Neoplasm
  • Hepatocellular Carcinoma
  • Pegylated Recombinant Human Arginase I
  • Hong Kong, Hong Kong
    Division of Hepatobiliary and Pancreatic Surgery, Department of
Mar 13, 2012

Tumor, Hepatocellular Carcinoma Trial in Hong Kong (Pegylated Recombinant Human Arginase I, Doxorubicin)

Completed
  • Neoplasm
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Division of Hepatobiliary and Pancreatic Surgery, Department of
Mar 13, 2012

Cancer, Liver Cancer, Primary Liver Cancer Trial in Worldwide (PI-88, )

Terminated
  • Cancer
  • +4 more
  • United States of America, New York
  • +9 more
Jun 13, 2011

Hepatocellular Carcinoma Trial in China, United States (intravenous T900607-sodium)

Unknown status
  • Hepatocellular Carcinoma
  • intravenous T900607-sodium
  • La Jolla, California
  • +11 more
Jun 23, 2005

Hepatocellular Carcinoma Trial in Worldwide (T138067 intravenous, doxorubicin intravenous)

Terminated
  • Hepatocellular Carcinoma
  • T138067 intravenous
  • doxorubicin intravenous
  • Birmingham, Alabama
  • +75 more
Jun 23, 2005